Center for Translational Science Activities, Mayo Clinic, Rochester, MN 55905, USA.
Circ Res. 2013 Aug 16;113(5):571-87. doi: 10.1161/CIRCRESAHA.113.301765.
Recent advances in the burgeoning field of genome engineering are accelerating the realization of personalized therapeutics for cardiovascular disease. In the postgenomic era, sequence-specific gene-editing tools enable the functional analysis of genetic alterations implicated in disease. In partnership with high-throughput model systems, efficient gene manipulation provides an increasingly powerful toolkit to study phenotypes associated with patient-specific genetic defects. Herein, this review emphasizes the latest developments in genome engineering and how applications within the field are transforming our understanding of personalized medicine with an emphasis on cardiovascular diseases.
近年来,基因组工程领域的新兴技术正在加速实现心血管疾病的个体化治疗。在后基因组时代,序列特异性基因编辑工具使我们能够对与疾病相关的遗传改变进行功能分析。与高通量模型系统相结合,高效的基因操作提供了一个日益强大的工具包,用于研究与患者特异性遗传缺陷相关的表型。本文强调了基因组工程的最新进展,以及该领域的应用如何改变我们对个性化医学的理解,重点是心血管疾病。